Kodiak Sciences (KOD) Asset Writedowns and Impairment (2025)
Kodiak Sciences (KOD) posted Asset Writedowns and Impairment of $1.9 million for Q1 2025.
Kodiak Sciences (KOD) Asset Writedowns and Impairment (2025) Analysis & Trends
Kodiak Sciences' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $1.9 million for Q1 2025.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $1.9 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (changed N/A YoY) and the FY2025 annual result came in at $1.9 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $1.9 million for Q1 2025 at Kodiak Sciences.
- Across five years, Asset Writedowns and Impairment topped out at $1.9 million in Q1 2025 and bottomed at $1.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Kodiak Sciences | 2.61 Bn | 2.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |